| |
| |
|
| Insider
Information: |
D Alonzo Thomas |
| Relationship: |
Acting President and C... |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
Acting President and C... |
2015-04-01 |
0 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-06-08 |
4 |
S |
$51.63 |
$131,657 |
I/I |
(2,550) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$3,164,170 |
I/I |
(18,290) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$3,638,536 |
D/D |
(21,032) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Acting President and CEO |
• • – |
2015-04-01 |
4 |
D |
$173.00 |
$12,898,015 |
D/D |
(74,555) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-10-07 |
4 |
B |
$38.00 |
$9,880 |
I/I |
260 |
260 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-12-01 |
4 |
B |
$44.80 |
$22,399 |
I/I |
500 |
500 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-08-11 |
4 |
B |
$29.77 |
$17,267 |
I/I |
580 |
1,080 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2000-06-29 |
4 |
B |
$1.73 |
$10,380 |
I/I |
6,000 |
2,000 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2001-03-13 |
4 |
B |
$13.75 |
$6,875 |
I/I |
500 |
2,500 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2006-11-13 |
4 |
S |
$13.17 |
$15,814 |
I/I |
(1,200) |
2,550 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-02-12 |
4 |
S |
$27.93 |
$83,790 |
I/I |
(3,000) |
3,500 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-02-11 |
4 |
S |
$26.50 |
$278,741 |
I/I |
(10,500) |
4,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2002-11-07 |
4 |
B |
$8.40 |
$8,400 |
I/I |
1,000 |
5,000 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2002-08-01 |
4 |
B |
$7.00 |
$56,080 |
I/I |
8,000 |
6,000 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2002-11-27 |
4 |
B |
$9.72 |
$4,860 |
I/I |
500 |
6,500 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2006-05-08 |
4 |
B |
$13.01 |
$78,076 |
I/I |
6,000 |
6,500 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2001-08-01 |
4 |
B |
$7.02 |
$84,300 |
I/I |
12,000 |
8,000 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-11-26 |
4 |
B |
$15.15 |
$91,014 |
I/I |
6,000 |
8,250 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-11-29 |
4 |
B |
$15.15 |
$45,707 |
I/I |
3,000 |
9,250 |
2.1 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2014-01-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,450 |
10,450 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-02-11 |
4 |
S |
$26.60 |
$106,400 |
D/D |
(4,000) |
14,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2002-08-01 |
4 |
B |
$7.03 |
$56,240 |
D/D |
8,000 |
18,000 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-11-26 |
4 |
B |
$15.16 |
$60,878 |
D/D |
4,000 |
25,000 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-11-29 |
4 |
B |
$15.15 |
$45,599 |
D/D |
3,000 |
28,000 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2006-05-08 |
4 |
B |
$13.01 |
$11,709 |
D/D |
900 |
28,900 |
2.39 |
- |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
